SNCA and Parkinson disease: Neurodegeneration in PD may be a result of diverse pathogenic pathways, including the toxicity of soluble and insoluble aggregated α-synuclein, mitochondrial dysfunction, defective proteolysis due to ubiquitin-proteasome system dysfunction, oxidative stress, and inflammation9–11.